Momo Medical
-34%
est. 2Y upside i
We help nurses in nursing homes to be 30% more effective
Rank
#40
Sector
HealthTech
Est. Liquidity
~5Y
Data Quality
Data: HighMomo Medical presents a strong upside opportunity for a job seeker, with an estimated 182.5% expected upside over a two-year horizon.
Last updated: March 10, 2026
Strong market adoption driven by the patented bed sensor technology and successful expansion into new care settings or geographies. Revenue could reach $20M-$25M by 2026, justifying a $200M valuation at 8-10x revenue multiple, representing a 5x return on current valuation.
Momo Medical maintains its strong growth trajectory, albeit at a moderating pace, and solidifies its market position. Revenue grows to $12M-$15M by 2026, leading to a $100M valuation at 7-8x revenue multiple, a 2.5x return.
Slower than anticipated market adoption due to regulatory hurdles or increased competition from larger healthcare technology companies. Growth stalls, and a down round or failure to secure next funding leads to a $12M valuation, wiping out a significant portion of common stock value.
Preference Stack Risk
highInvestors hold $9M in liquidation preferences, meaning common shareholders would only see returns after this amount is paid out in an exit at or below the estimated $40M current valuation.
Dilution Risk
highAs a Series A company, Momo Medical will likely require at least one to two more significant funding rounds, which will dilute existing common shareholders' equity percentage.
Secondary Liquidity
noneThere is currently no active secondary market for shares in a Series A company of this size, limiting early liquidity options for employees.
Questions to Ask at the Interview
Strategic questions based on Momo Medical's data — designed to show you've done your homework.
- 1
“Momo Medical's patented bed sensor technology provides a strong competitive moat. How do you plan to leverage this technological advantage to expand into new care settings or geographies beyond nursing homes, and what regulatory challenges do you foresee in those expansions?”
- 2
“With impressive YoY growth of 246% and $4M in revenue, what are the key milestones and financial targets the company is focused on achieving in the next 18-24 months to prepare for a successful Series B or C funding round?”
- 3
“Given the Series A funding and the typical timeline for venture-backed companies, how does Momo Medical envision the path to a liquidity event for employees, and what are the company's thoughts on potential secondary liquidity options as the company matures?”
Community
Valuation Sentiment
Our model estimates -34% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.